News

open PR. com
openpr. com > news > 4517923 > pleural-diseases-therapeutics-market-expands-with

Pleural Diseases Therapeutics Market Expands with Immuno-Oncology Adoption: Why Advanced Thoracic Care Is Creating an USD 11. 06 Billion Opportunity

4+ hour, 9+ min ago  (70+ words) Pleural Diseases Therapeutics Market Expands with open PR. com Pleural Diseases Therapeutics Market Expands with Immuno-Oncology Adoption: Why Advanced Thoracic Care Is Creating an USD 11. 06 Billion Opportunity Press release from: Future Market Insights Inc Permanent link to this press release:…...

Symbols: btc-usd
Pharm Exec
pharmexec. com > view > investors-should-expect-current-regulatory-environment

What Pharma Investors Should Expect in the Current Regulatory Environment

3+ day, 13+ hour ago  (312+ words) Marty Makary is the latest key leader at HHS to leave their role over the past two years. Aside from the coming and going of important roles, the current administration also has plans to majorly overhaul FDA and the drug…...

Symbols: btc-usd
CHEManager
chemanager-online. com

Hongene Backs Siran Bio's RNAi Pipeline with Advanced CDMO Support

53+ min ago  (252+ words) Programs like SA1211 show where the field is heading," said David Butler, Chief Technology Officer at Hongene. As si RNA designs become more complex, the bar for development and CMC execution rises with them. Our role is to give customers the…...

Symbols: nasdaq:srpt
Trading View
tradingview. com > news > modular_finance: 739052cfc4966: 0-biostock-launches-consensus-analysis-a-new-analytical-format-for-nordic-life-science

Bio Stock launches Consensus Analysis " a new analytical format for Nordic life science

1+ hour, 59+ min ago  (210+ words) Bio Stock today announces the launch of Consensus Analysis, a new editorial format that aggregates and interprets analyst panel views on listed life science companies around quarterly earnings. The inaugural edition focuses on Novo Nordisk. Published today, on 19 May 2026, the…...

Symbols: nasdaq:pacb
Apex Onco
oncologypipeline. com > apexonco > aktis-takes-second-asset-human-trials

Aktis takes a second asset into human trials

2+ hour, 18+ min ago  (298+ words) I am very impressed - it has become my go-to platform" US public biotech company Oncology Pipeline is my favorite CI tool" Head of Market Insights Oncology Europe The recent Nasdaq entrant prepares to move AKY-2519 into the clinic. Aktis Oncology,…...

Symbols: nasdaq:akts,nasdaq:akba
The National Tribune
nationaltribune. com. au > queensland-government-lures-biomed-business-and-jobs-to-queensland

Queensland Government lures biomed business and jobs to Queensland

8+ hour, 53+ min ago  (598+ words) The Crisafulli Government has lured Victoria-based Clinical Trial Group to set up shop in Queensland, investing $11. 2 million through the flagship $180. 6 million Sovereign Industry Development Fund. Clinical Trials Group will expand into Queensland with the establishment of a new 40+ bed Phase…...

Symbols: btc-usd,lthm.cn,mdma.ne,mdma.cn,rup.ne,rup.to
Google News
natlawreview. com > press-releases > 22x-cost-advantage-70-revenue-share-why-small-molecules-are-defying

22x Cost Advantage, 70% Revenue Share-Why Small Molecules are Def

3+ hour, 13+ min ago  (184+ words) NEW YORK, NY, UNITED STATES, May 19, 2026 /EINPresswire. com/ -- "The Future of Small Molecules-Why Chemistry is Far from Dead," - The recent webinar by Stellarix delved into why chemistry is thriving at the cutting edge of science and remains strategically relevant in…...

Symbols: nyse:lly,nyse:nvo
Google News
globalventuring. com > corporate > healthcare > organoids-ai-meets-the-end-of-animal-testing

Organoids: AI meets the end of animal testing

1+ hour, 14+ min ago  (291+ words) Biopharma company MSD has taken considered bets on healthcare AI, from drug discovery platforms to diagnostics. Here's why the team's AI lead, David Rubin, sees tiny human tissue models as the next emerging area. The Global Health Innovation Fund had…...

Symbols: btc-usd
Pluang
pluang. com > en > news-feed > coiled-therapeutics-mulai-perdagangan-di-pasar-otcqb-as

Coiled Therapeutics starts US OTCQB trading to. .. | Pluang " Crypto, Stocks, Gold & Funds

7+ hour, 5+ min ago  (269+ words) Coiled Therapeutics, a clinical-stage oncology company, has begun trading on the US OTCQB Venture Market under the ticker COTXF, allowing US investors to buy shares in dollars during US market hours. This move aims to improve liquidity and broaden its…...

Symbols: nasdaq:btbt,nasdaq:mdcx
PA Media
pressreleasehub. pa. media > article > sino-biological-launches-xpressmax-cell-free-protein-synthesis-kit-accelerating-ai-powered-high-throughput-antibody-drug-discovery-74137. html

Sino Biological Launches XPress MAX" Cell-Free Protein Synthesis Kit, Accelerating AI-Powered High-Throughput Antibody Drug Discovery

1+ hour, 47+ min ago  (129+ words) PA Media Accelerating Drug Discovery: Tsingke Biotech Unveils Next-Generation Rapid Protein and Antibody Solutions Gen Script Launches Turbo CHO" Protein Expression Kit, Delivering the Fastest Path to Antibodies in its Class Sino Biological's Launch of Swift Fluo" TR-FRET Kits Pioneers…...

Symbols: btc-usd,nasdaq:mxct